Infectious Diseases

Host: Neilanjan Nandi, MD, FACP

The COVID-19 pandemic has presented a unique set of challenges for healthcare professionals. What are some of the biggest threats to our GI patients, and how should we help them stay safe? Here today is our GI Insights host, Dr. Neil Nandi, to shed some light on his experiences while caring for patients during the pandemic.

Host: John Russell, MD

Guest: Christopher Haines, MD, MA

The COVID-19 pandemic has altered the field of medicine. To better understand the science behind this virus while putting this pandemic into historical perspective, Dr. Christopher Haines shares his experiences caring for patients during the pandemic and describes what drove him to write his book: COVID-19 Essays from the Front: The First Six Months.

Guest: John Russell, MD

With so many COVID-19 vaccines in development, new medical ethical questions have been brought to the forefront of the healthcare field. With that in mind, Dr. John Russell takes us through the history of ethics and vaccinations throughout the world.

Published January 4, 2021

Host: Charles Turck, PharmD, BCPS, BCCCP

Guest: Patrice Harris, MD

The U.S. Centers for Disease Control and Prevention estimate that more than 80,000 Americans died from May 2019 to May 2020 due to a drug-related overdose. CDC data indicates that the drug overdose epidemic is being fueled by a staggering rise in deaths involving illicitly manufactured Fentanyl methamphetamine, cocaine and heroin.

In response to the far-reaching drug overdose epidemic, organizations like the American Medical Association and Manatt Health have come together to help end this epidemic. Here to recap the process that’s been made and what the 2020 national policy roadmap recommends moving towards is Dr. Patrice Harris a psychiatrist and chair of the AMA Opioid Task Force.

Host: Linda Bernstein, Pharm.D.

The U.S. Food and Drug Administration issued an emergency use authorization, or EUA, for the Moderna COVID-19 vaccine. The second vaccination to achieve EUA designation, the Moderna vaccine will be distributed throughout the US for patients 18 years and older. In this episode of The Drug Report, Dr. Linda Bernstein discusses this newly-approved vaccine and how it compares to others.

Published December 29, 2020

Host: John Russell, MD

Guest: William G. Callahan, DO

The COVID-19 pandemic has compelled many to stay home, but for those venturing out, how can we encourage them to stay safe? Dr. Bill Callahan, a family physician at Abington Jefferson Health and outdoorsman, sits down with Dr. John Russell to discuss how to stay safe during this winter pandemic.

Host: Jacob Sands, MD

Guest: Nabil F. Saba, MD, FACP

Since head and neck cancer is still to a large extent a surgical disease, the COVID-19 pandemic had an immediate impact on its management. Here to share how he pivoted his approach and how the pandemic might impact the future of head and neck cancer care is Dr. Nabil Saba, a Professor and Vice Chair for Quality and Safety in the Department of Hematology and Medical Oncology at the Emory University School of Medicine.

Host: Jacob Sands, MD

Guest: Therese T. Bevers, MD

Fear of the COVID-19 pandemic has led to added safety precautions that have prevented patients from receiving much-needed cancer screenings. How will this impact the field of oncology, and what can we do to encourage patients to get their screenings? Dr. Therese Beavers, Medical Director of the Cancer Prevention Center at the University of Texas MD Anderson Cancer Center, joins Dr. Jacob Sands to discuss the fatal consequences of missed cancer screenings.

Host: Linda Bernstein, Pharm.D.

The first vaccine to receive Emergency Use Authorization from the US Food and Drug Administration, this authorization allows the Pfizer-BioNTech COVID-19 vaccine to be distributed throughout the US. But what do we know about this vaccine? In this episode of The Drug Report, Dr. Linda Bernstein discusses the Pfizer-BioNTech COVID-19 vaccine.

Published December 18, 2020

Host: Jennifer Caudle, DO

Guest: Kathleen Blake, MD, MPH

With E&M coding changes taking effect January 1, 2021, the AMA offers tools and resources for physician implementation. Dr. Kathleen Blake, Vice President of Healthcare Quality at the American Medical Association, joins Dr. Jennifer Caudle to share what we can expect.